Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664062 · ClinicalTrials.gov registry record · NA
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
A NA study of Opioid Use Disorder and Opioid Dependence, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 303
- Enrollment target
- 2
- Study locations
NCT04664062: Active NA study of Opioid Use Disorder and Opioid Dependence, sponsored by University of Colorado, Denver.
NCT04664062 is a NA study of Opioid Use Disorder and Opioid Dependence that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 303 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664062, a NA study of Opioid Use Disorder and Opioid Dependence, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
- 2
- Study locations
Study Summary
HOMER is a national study comparing three methods of induction for Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD); home versus office versus telehealth-based inductions. This study will help determine if certain patient and practice characteristics make patients better candidates for one method over the others. Results will help fill a gap in the evidence around effectively treating OUD with MAT in primary care settings.
Conditions Studied
Interventions
- BEHAVIORAL Medication Assisted Treatment
Study Locations (2)
Colorado
- University of Colorado - Denver
Kansas
- American Academy of Family Physicians National Research Network - Leawood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT04664062 still lists
NCT04664062 is an interventional study that assigns participants to a tested intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Medication Assisted Treatment is the first listed.
NCT04664062 reports a single indexed study location in Colorado, Kansas.
Frequently Asked Questions
What is clinical trial NCT04664062 about?
NCT04664062 is a clinical study titled "Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder". HOMER is a national study comparing three methods of induction for Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD); home versus office versus telehealth-based inductions. This study will help determine if certain patient and practice characteristics make patients better candidates ...
What is the current status of trial NCT04664062?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 303 participants. The study started on 2021-05-13. Estimated completion is 2026-02-28.
What conditions does trial NCT04664062 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Dependence.
What interventions are being tested in trial NCT04664062?
The interventions under investigation include: Medication Assisted Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04664062?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04664062 being conducted?
This trial has 2 study locations across Colorado, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04664062's enrollment target sits among peer trials
303 55th of 257 higher than 203 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI